Mar. 26 2024
Source Page: Whole of Government Accounts, 2021-22Found: Business Interruption Loan Scheme (CBILS)/Coronavirus Large Businesses Interruption Loan Scheme (CLBILS
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 April 2023 to Question 176541 on Vaccine Damage Payment Scheme: Coronavirus, which safety concerns relating to covid-19 vaccines have been the subject of advice for (a) healthcare professionals and (b) patients since January 2021.
Answered by Maria Caulfield
The United Kingdom Health Security Agency (UKHSA) publishes a range of resources to support healthcare professionals delivering the COVID-19 vaccination programme. Information on vaccine safety is available in the green book (chapter 14a), the primary professional source of guidance for front line immunisers, available at the following link:
https://www.gov.uk/government/publications/covid-19-the-green-book-chapter-14ai
Information on adverse events is available at the following links:
https://www.gov.uk/government/collections/covid-19-vaccination-and-rare-side-effects
UKHSA also produces patient information leaflets, which include information on rare side effects following vaccination. ‘What to expect after your COVID-19 vaccine’ is available at the following link:
https://www.gov.uk/government/publications/covid-19-vaccination-what-to-expect-after-vaccination
Vaccine safety remains at the forefront of the COVID-19 vaccine programme. The Medicines and Healthcare products Regulatory Agency is responsible for monitoring the safety of all COVID-19 vaccines approved in the United Kingdom.
Aug. 20 2024
Source Page: Standard personal medical services agreementFound: ) and 2008 SI 2008/653 (as amended); “NHS Scheme ” means the NHS Pension Scheme for England and Wales
Feb. 27 2024
Source Page: Supplementary Estimates 2023-24Found: Expenditure incurred in relation to the Covid-19 Vaccine Taskforce.
Feb. 27 2024
Source Page: Supplementary Estimates 2023-24Found: The Guarantee would not guarantee payment to the NAAFI Pension Scheme of NAAFI's obligations, as that
Aug. 20 2024
Source Page: Standard alternative provider medical services contractFound: ("the Scheme"); or 10.5A.2 not signed up to the Scheme but its Registered Patients or Temporary
Jan. 25 2024
Source Page: DHSC annual report and accounts: 2022 to 2023Found: A CETV is a payment made by a pension scheme or arrangement to secure pension benefits in another pension
Jan. 25 2024
Source Page: DHSC annual report and accounts: 2022 to 2023Found: A CETV is a payment made by a pension scheme or arrangement to secure pension benefits in another pension
Jul. 18 2024
Source Page: Criminal Proceedings in Scotland, 2021-22 – UpdatedFound: 2021-22 did not see the same court closures as 2020-21, this period spanned the early stages of the vaccine
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many applications there have been to the Vaccine Damage Payment Scheme relating to covid-19 vaccinations; and how many claims have been (a) awarded, (b) rejected and (c) were unresolved for more than six months.
Answered by Maria Caulfield
As of 1 September 2023, the NHS Business Services Authority has received 7,160 claims to the Vaccine Damage Payment Scheme (VDPS) that relate to COVID-19.
Following medical assessment, 142 (just under 2%) of these claims have been awarded and 3,030 (42.3%) of these claims have been rejected. A further 192 (2.7%) claims were found to be ‘invalid’ (for example, outside the scope of the VDPS, or a duplicate claim).
There are 3,796 currently unresolved claims, 1,010 of which (14.1% of the total number of COVID-19 related claims) have been unresolved for more than six months.